- Action
- Philips Medical notified consignees on about 10/06/2026 via certified mailed letter titled "URGENT Medical Device Correction." Consignees were instructed that affected systems may continue to be used in accordance with their Instructions for Use (IFU) and the additional instructions provided, which include: if motorized movements become unavailable, the stand can be manually repositioned using the handgrips and brake controls located on both sides of the stand. For ceiling-mounted systems, manual longitudinal (1), transversal (2), and rotational (3) stand movements remain available. Note: Transversal stand movements (2) are only available for ceiling-mounted systems with the FlexMove option. For floor-mounted systems, only rotational (3) stand movements remain available. The table longitudinal position (4) can be adjusted manually when the table is not tilted.
Additionally, consignees were instructed to ensure the notification letter is distributed to all relevant users, maintained with the device documentation until corrective actions are completed, to post the letter near affected devices for ease of reference, notify customers/organizations if affected systems have been distributed or transferred, and complete and return the response form provided.
Philips will inspect all systems in scope and replace SSDs that are not specified in the Medical Device File. Philips expects to start the implementation of this correction in December 2026. A local Philips representative will contact consignees to schedule a visit for a Field Service Engineer to perform these activities.
- Initiated
- 2026-10-06
- Root cause
- Equipment maintenance
- Distribution
- Worldwide distribution - US Nationwide and the countries of Afghanistan, Albania, Algeria, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahrain, Bangladesh, Belarus, Belgium, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Brunei Darussal, Bulgaria, Cambodia, Canada, Cayman Islands, Chile, China, Colombia, Costa Rica, C¿te D'Ivoire, Croatia, Cyprus, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Ethiopia, Finland, France, Germany, Greece, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Japan, Jordan, Kazakhstan, Kenya, Korea, South, Kosovo, Kuwait, Kyrgyzstan, Latvia, Lebanon, Libya, Lithuania, Macao, Macedonia, Malaysia, Maldives, Malta, Mauritania, Mauritius, Mexico, Moldova, Mongolia, Morocco, Myanmar, Nepal, Netherlands, New Zealand, Nicaragua, Nigeria, Norway, Oman, Pakistan, Palestine, Panama, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russian Federation, Saudi Arabia, Senegal, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sri Lanka, Sweden, Switzerland, Syrian Arab Republic, Taiwan, Tanzania, Thailand, Tunisia, Turkey, Turkmenistan, Ukraine, United Arab Emirates, United Kingdom, Uruguay, Uzbekistan, Vietnam, Yemen.
- Recall number
- Z-0293-2027
- Recall status
- Open, Classified
- CDRH record ID
- 222981
- FDA classified
- 2026-10-27
- Recall event number
- 99939